Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 2 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Recurrence 1 Medulloblastoma 1 Ependymoma 1 Brain Neoplasms 1

Interventions

Temozolomide 163 Radiosurgery 128 Radiotherapy 106 Bevacizumab 97 Magnetic Resonance Spectroscopy 74 Carboplatin 48 Surgical Procedures, Operative 35 Etoposide 34 pembrolizumab 33 Radiation 33 Nivolumab 33 Irinotecan 33 Cyclophosphamide 33 Erlotinib Hydrochloride 31 Carmustine 28 Trastuzumab 25 Lomustine 25 Cisplatin 25 Ipilimumab 24 Filgrastim 23 Mental Status and Dementia Tests 21 Magnetic Resonance Imaging 21 Aminolevulinic Acid 21 Vincristine 20 Surveys and Questionnaires 19 Capecitabine 19 Topotecan 18 Specimen Handling 18 Pemetrexed 18 Radiotherapy, Intensity-Modulated 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × trofosfamide × Clear all

NCT00749723 2018-07-20

HIT-REZ-2005

University Hospital, Bonn

Phase 2/3 Completed

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡